Name: Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography (Video) | JoVE Journal
Uploaded: 2022-12-02T14:10:00.000+00:00
Duration: 5 min 46 s
Description: Learn to implant and evaluate melanoma in the murine choroid using optical coherence tomography for live tumor imaging. This method enables reproducible tumor induction and continuous monitoring to advance uveal melanoma research.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

This study was supported in part by grant 1304/20 from the Israel Science Foundation (ISF), Israel, for Arie Marcovich. We thank Shahar Ish-Shalom&#160;and Ady Yosipovich, from the Department of Pathology, Kaplan Medical Center, Rehovot, Israel, for histology analysis.

The experiments in the protocol were approved by the Israeli National Council on Animal Experimentation and comply with the ARVO Statement for using Animals in Ophthalmic and Vision Research. Female C57BL/6 mice, aged 8-10 weeks, were used for the present study and were exposed to 12/12 h light-dark cycles. The animals were obtained from a commercial source (see Table of Materials).
1. Cell culture
<ol>
	<li>Culture B16LS9 cells in RPMI 1640 medium, supplemented with 10% fetal bovine serum, 2 mM L-glutamine, 1 mM sodium pyruvate, 25 mM HEPES, 1% essential vitamin mixture, 200 U/mL penicillin, and 200 mg/mL streptomycin (see Table of Materials), in a humidified 37 °C incubator with 5% CO2.</li>
	<li>Harvest the cells for injection at 70%-80% confluence.</li>
</ol>
2. Animal preparation
<ol>
	<li>Prepare an anesthetic mixture of ketamine (75 mg/kg body weight) and medetomidine (0.5 mg/kg body weight). Anesthetize the mice by injecting the anesthetic mixture intraperitoneally in a single injection.</li>
	<li>Apply topical ophthalmic anesthetic oxybuprocaine (0.4%) to both eyes.</li>
	<li>Dilate the mouse pupils by topically applying tropicamide (0.5%).</li>
</ol>
3. Creating a conjunctival peritomy and scleral tract into sub-choroidal space
<ol>
	<li>Apply 1.4% hydroxyethylcellulose (see Table of Materials) as a lubricant to both eyes to avoid drying. Apply 0.5% tropicamide to the right eye.</li>
	<li>Observe the operated eye of the mouse under an operating microscope (see Table of Materials). Hold the eyelids open with sterile intraocular forceps.</li>
	<li>Using intraocular forceps, hold the supero-temporal limbal conjunctiva and pull toward an infra-nasal position22. Secure this position by holding it throughout the whole procedure (Figure 1A).</li>
	<li>Using a 30 G needle tip, make a small (1-2 mm) conjunctival peritomy in the dorsal-temporal area, approximately 1-2 mm posterior to the limbus. 
	NOTE: Using finer needles can prevent excessive puncture and allow better precision of tumor location.</li>
	<li>Remove excess Tenon's capsule from the opening of the peritomy. 
	NOTE: Tenon's capsule is a layer of dense connective tissue that surrounds the globe of the eye22.</li>
	<li>In this location, insert the needle tip to penetrate through the sclera. Make an excision to create a tract into the sub-choroidal space until the brown color of the choroid appears through the exposed white matter of the sclera (Figure 1B).</li>
</ol>
<img alt="eye surgery procedure; sequence of steps for intraocular lens insertion; surgical method; ophthalmology" class="xfigimg" src="/files/ftp_upload/64632/64632fig01.jpg" data-altupdatedat="1788304762000" data-alt="Figure 1"> 
Figure 1: Tumor cell inoculation. (A) The supero-temporal limbal conjunctiva is held using intraocular forceps and pulled toward an infra-nasal position. (B) The tip of a 30 G needle is inserted to penetrate through the sclera, and excision is made to create a track into the sub-choroidal space. (C) A syringe loaded with cells and mounted with a 32 G needle is inserted into the track, and the cells are injected. <a href="https://www.jove.com/files/ftp_upload/64632/64632fig01large.jpg" target="_blank">Please click here to view a larger version of this figure.</a>
4. Inoculation of melanoma cells
<ol>
	<li>Resuspend 70,000 B16LS9 cells in 2 µL of PBS. This amount is estimated per eye.</li>
	<li>Load the cells into a sterile 10 µL glass Hamilton syringe (see Table of Materials) mounted with a 32 G blunt needle twisted at a 45° angle.</li>
	<li>Insert the loaded syringe needle approximately 2 mm into the track created in step 3.</li>
	<li>Inject 2 µL of cell suspension.</li>
	<li>Hold the needle in place after injection for 2-3 s until all fluid has cleared.</li>
	<li>Remove the needle by pulling it out gently and slowly to avoid leakage from the track (Figure 1C). 
	NOTES: Adjusting the speed and force of injection can affect the pattern of tumor development. It is suggested that these parameters be calibrated by individuals experimenting to identify the right force and speed applied. A total of 70,000 cells was determined in preliminary experiments. However, as there may be variations in cell culture types or batches or between mouse strains, calibration of this number is necessary.</li>
</ol>
5. Assessing the location of the injection
<ol>
	<li>Observe the injected eye by OCT scans immediately after melanoma cell inoculation to identify the appearance of retinal detachment (RD), retinal damage, and/or cells at the vitreous23. 
	NOTES: Re-apply tropicamide, oxybuprocaine, and ethylcellulose as necessary.</li>
	<li>Based on the OCT scans from step 5.1, classify the RD patterns21 according to: (1) local RD-one site of RD; (2) leakage into the vitreous-observing cell material in the vitreous; (3) extended RD-multiple sites of RD.</li>
	<li>Predict the tumor localization based on: (1) local RD-expected choroidal tumors; (2) leakage into the vitreous-expected tumors in the vitreous; (3) extended RD-expected variable and dispersed tumors (Figure 2). 
	​NOTE: Only mice with local RD (about 50%) are expected to develop tumors that are limited to the choroid.</li>
</ol>
6. Predicting tumor size based on RD height
<ol>
	<li>Measure the height of local RD in the OCT scans using an OCT segmentation/analysis software (see Table of Materials) and classify according to the following groups: small = &lt;300 µm; medium = 300-400 µm; large = &gt;400 µm.</li>
	<li>Assess the volume that the tumors are expected to reach within 5 days from injection according to the following criteria: 
	A small RD height is typically observed in small-sized tumors (tumor volume ranging from 0.0059 mm3 to 0.07 mm3 with a mean volume of 0.027 ± 0.005 mm3). 
	A medium RD height is found in both small and medium-sized tumors (tumor volume ranging from 0.015 mm3 to 0.15 mm3 with a mean volume of 0.056 ± 0.016 mm3). 
	A large RD height is associated with a wide range of tumor volumes up to 0.36 mm3. 
	NOTE: The range of expected tumor sizes was obtained from the previous results and divided into three groups of small, medium, and large tumors.</li>
</ol>
7. Postoperative procedures
<ol>
	<li>Apply ophthalmic ofloxacin 0.3% topically.</li>
	<li>Reverse the anesthesia by injecting atipamezole hydrochloride (3 mg/kg) subcutaneously.</li>
	<li>Subcutaneously inject buprenorphine (0.05 mg/kg body weight) twice a day for 3 days to reduce the pain and suffering of animals.</li>
	<li>At 5 days after melanoma cell injection, evaluate tumor size by following the steps below.
	<ol>
		<li>Anesthetize the mice as described in step 2.1. Apply tropicamide (0.5%).</li>
		<li>Examine the eyes by longitudinal and sagittal OCT scans and use OCT segmentation/analysis software to measure tumor volume and localization.</li>
		<li>Calculate tumor volume using the formula24: V = a*b*c*6/π (a, b, and c = length, width, and height, respectively).</li>
		<li>Examine tumor size every 2-3 days as described in steps 7.4.1-7.4.3. 
		NOTE: The procedure must be optimized if using different mouse strains or cell lines.</li>
	</ol>
	</li>
</ol>

<ol><li>Jager, M. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Uveal+melanoma%5BTitle%5D)+AND+%22Nature+Reviews+Disease+Primers%22%5BJournal%5D)">Uveal melanoma.</a> Nature Reviews Disease Primers. 6 (1), 1-25 (2020).</li>
<li>Bustamante, P., Piquet, L., Landreville, S., Burnier, J. V. Uveal melanoma pathobiology: Metastasis to the liver. <a target="_blank" href="http://scholar.google.com/scholar?hl=en&safe=off&q=author%3aBustamante%2C+P+%22Seminars+in+Cancer+Biology%22">Seminars in Cancer Biology</a>. 71, Academic Press. 65-85 (2021).</li>
<li>Damato, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Ocular+treatment+of+choroidal+melanoma+in+relation+to+the+prevention+of+metastatic+death-A+personal+view%5BTitle%5D)+AND+%22Progress+in+Retinal+and+Eye+Research%22%5BJournal%5D)">Ocular treatment of choroidal melanoma in relation to the prevention of metastatic death-A personal view.</a> Progress in Retinal and Eye Research. 66, 187-199 (2018).</li>
<li>Jouhi, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+small+fatal+choroidal+melanoma+study.+A+survey+by+the+European+Ophthalmic+Oncology+Group%5BTitle%5D)+AND+%22American+Journal+of+Ophthalmology%22%5BJournal%5D)">The small fatal choroidal melanoma study. A survey by the European Ophthalmic Oncology Group.</a> American Journal of Ophthalmology. 202, 100-108 (2019).</li>
<li>Cao, J., Jager, M. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Animal+eye+models+for+uveal+melanoma%5BTitle%5D)+AND+%22Ocular+Oncology+and+Pathology%22%5BJournal%5D)">Animal eye models for uveal melanoma.</a> Ocular Oncology and Pathology. 1 (3), 141-150 (2015).</li>
<li>Uner, O. E., Gandrakota, N., Azarcon, C. P., Grossniklaus, H. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Animal+models+of+uveal+melanoma%5BTitle%5D)+AND+%22Annals+of+Eye+Science%22%5BJournal%5D)">Animal models of uveal melanoma.</a> Annals of Eye Science. 7, 21-30 (2022).</li>
<li>Yang, H., Dithmar, S., Grossniklaus, H. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Interferon+alpha+2b+decreases+hepatic+micrometastasis+in+a+murine+model+of+ocular+melanoma+by+activation+of+intrinsic+hepatic+natural+killer+cells%5BTitle%5D)+AND+%22Investigative+Ophthalmology+%26+Visual+Science%22%5BJournal%5D)">Interferon alpha 2b decreases hepatic micrometastasis in a murine model of ocular melanoma by activation of intrinsic hepatic natural killer cells.</a> Investigative Ophthalmology & Visual Science. 45 (7), 2056-2064 (2004).</li>
<li>Yang, H., Grossniklaus, H. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Combined+immunologic+and+anti-angiogenic+therapy+reduces+hepatic+micrometastases+in+a+murine+ocular+melanoma+model%5BTitle%5D)+AND+%22Current+Eye+Research%22%5BJournal%5D)">Combined immunologic and anti-angiogenic therapy reduces hepatic micrometastases in a murine ocular melanoma model.</a> Current Eye Research. 31 (6), 557-562 (2006).</li>
<li>Rusciano, D., Lorenzoni, P., Burger, M. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Murine+models+of+liver+metastasis%5BTitle%5D)+AND+%22Invasion+%26+Metastasis%22%5BJournal%5D)">Murine models of liver metastasis.</a> Invasion & Metastasis. 14 (1-6), 349-361 (1994).</li>
<li>Diaz, C. E., Rusciano, D., Dithmar, S., Grossniklaus, H. E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((B16LS9+melanoma+cells+spread+to+the+liver+from+the+murine+ocular+posterior+compartment+%28PC%29%5BTitle%5D)+AND+%22Current+Eye+Research%22%5BJournal%5D)">B16LS9 melanoma cells spread to the liver from the murine ocular posterior compartment (PC).</a> Current Eye Research. 18 (2), 125-129 (1999).</li>
<li>Rusciano, D., Lorenzoni, P., Burger, M. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Murine+models+of+liver+metastasis%5BTitle%5D)+AND+%22Invasion+%26+Metastasis%22%5BJournal%5D)">Murine models of liver metastasis.</a> Invasion & Metastasis. 14 (1-6), 349-361 (1994).</li>
<li>Ashur-Fabian, O., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Tetrac+delayed+the+onset+of+ocular+melanoma+in+an+orthotopic+mouse+model%5BTitle%5D)+AND+%22Frontiers+in+Endocrinology%22%5BJournal%5D)">Tetrac delayed the onset of ocular melanoma in an orthotopic mouse model.</a> Frontiers in Endocrinology. 12, 632335(2019).</li>
<li>Elia, G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mechanisms+regulating+c-met+overexpression+in+liver-metastatic+B16-LS9+melanoma+cells%5BTitle%5D)+AND+%22Journal+of+Cellular+Biochemistry%22%5BJournal%5D)">Mechanisms regulating c-met overexpression in liver-metastatic B16-LS9 melanoma cells.</a> Journal of Cellular Biochemistry. 81 (3), 477-487 (2001).</li>
<li>Harning, R., Szalay, Z. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Ocular+metastasis+of+in+vivo+and+in+vitro+derived+syngeneic+murine+melanoma%5BTitle%5D)+AND+%22Investigative+Ophthalmology+%26+Visual+Science%22%5BJournal%5D)">Ocular metastasis of in vivo and in vitro derived syngeneic murine melanoma.</a> Investigative Ophthalmology & Visual Science. 28 (9), 1599-1604 (1987).</li>
<li>Ezra-Elia, R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Can+an+in+vivo+imaging+system+be+used+to+determine+localization+and+biodistribution+of+AAV5-mediated+gene+expression+following+subretinal+and+intravitreal+delivery+in+mice%5BTitle%5D)+AND+%22Experimental+Eye+Research%22%5BJournal%5D)">Can an in vivo imaging system be used to determine localization and biodistribution of AAV5-mediated gene expression following subretinal and intravitreal delivery in mice.</a> Experimental Eye Research. 176, 227-234 (2018).</li>
<li>Notting, I. C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Whole-body+bioluminescent+imaging+of+human+uveal+melanoma+in+a+new+mouse+model+of+local+tumor+growth+and+metastasis%5BTitle%5D)+AND+%22Investigative+Ophthalmology+%26+Visual+Science%22%5BJournal%5D)">Whole-body bioluminescent imaging of human uveal melanoma in a new mouse model of local tumor growth and metastasis.</a> Investigative Ophthalmology & Visual Science. 46 (5), 1581-1587 (2005).</li>
<li>Yang, H., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((In-vivo+xenograft+murine+human+uveal+melanoma+model+develops+hepatic+micrometastases%5BTitle%5D)+AND+%22Melanoma+Research%22%5BJournal%5D)">In-vivo xenograft murine human uveal melanoma model develops hepatic micrometastases.</a> Melanoma Research. 18 (2), 95-103 (2008).</li>
<li>Murthy, R. K., Haji, S., Sambhav, K., Grover, S., Chalam, K. V. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Clinical+applications+of+spectral+domain+optical+coherence+tomography+in+retinal+diseases%5BTitle%5D)+AND+%22Biomedical+Journal%22%5BJournal%5D)">Clinical applications of spectral domain optical coherence tomography in retinal diseases.</a> Biomedical Journal. 39 (2), 107-120 (2016).</li>
<li>Drexler, W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Ultrahigh-resolution+ophthalmic+optical+coherence+tomography%5BTitle%5D)+AND+%22Nature+Medicine%22%5BJournal%5D)">Ultrahigh-resolution ophthalmic optical coherence tomography.</a> Nature Medicine. 7 (4), 502-507 (2001).</li>
<li>Ochakovski, G. A., Fischer, M. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Phenotyping+of+mouse+models+with+OCT%5BTitle%5D)+AND+%22Methods+in+Molecular+Biology%22%5BJournal%5D)">Phenotyping of mouse models with OCT.</a> Methods in Molecular Biology. 1834, 285-291 (2019).</li>
<li>Zaks, O., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((In-vivo+imaging+for+assessing+tumor+growth+in+mouse+models+of+ocular+melanoma%5BTitle%5D)+AND+%22Experimental+Eye+Research%22%5BJournal%5D)">In-vivo imaging for assessing tumor growth in mouse models of ocular melanoma.</a> Experimental Eye Research. 204, 108431(2021).</li>
<li>Brar, V. S. American Academy of Ophthalmology 2022-2023 BCSC. 2. <a target="_blank" href="http://scholar.google.com/scholar?hl=en&safe=off&q=author%3aBrar%2C+VS+%22Fundamentals+and+principles+of+ophthalmology%22">Fundamentals and principles of ophthalmology</a>. , (2022).</li>
<li>Duker, J. S., Waheed, N. K., Goldman, D. <a target="_blank" href="http://scholar.google.com/scholar?hl=en&safe=off&q=author%3aDuker%2C+JS+%22Handbook+of+Retinal+OCT%3A+Optical+Coherence+Tomography%2C+2nd+Edition%22">Handbook of Retinal OCT: Optical Coherence Tomography, 2nd Edition</a>. , Elsevier Health Sciences. (2021).</li>
<li>Tomayko, M. M., Reynolds, C. P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Determination+of+subcutaneous+tumor+size+in+athymic+%28nude%29+mice%5BTitle%5D)+AND+%22Cancer+Chemotherapy+and+Pharmacology%22%5BJournal%5D)">Determination of subcutaneous tumor size in athymic (nude) mice.</a> Cancer Chemotherapy and Pharmacology. 24 (3), 148-154 (1989).</li>
<li>Richards, J. R., Yoo, J. H., Shin, D., Odelberg, S. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Mouse+models+of+uveal+melanoma%3A+Strengths%2C+weaknesses%2C+and+future+directions%5BTitle%5D)+AND+%22Pigment+Cell+%26+Melanoma+Research%22%5BJournal%5D)">Mouse models of uveal melanoma: Strengths, weaknesses, and future directions.</a> Pigment Cell & Melanoma Research. 33 (2), 264(2020).</li>
<li>Chen, R., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Photoacoustic+molecular+imaging-escorted+adipose+photodynamic-browning+synergy+for+fighting+obesity+with+virus-like+complexes%5BTitle%5D)+AND+%22Nature+Nanotechnology%22%5BJournal%5D)">Photoacoustic molecular imaging-escorted adipose photodynamic-browning synergy for fighting obesity with virus-like complexes.</a> Nature Nanotechnology. 16 (4), 455-465 (2021).</li>
<li>Yu, Q., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Label-free+visualization+of+early+cancer+hepatic+micrometastasis+and+intraoperative+image-guided+surgery+by+photoacoustic+imaging%5BTitle%5D)+AND+%22Journal+of+Nuclear+Medicine%22%5BJournal%5D)">Label-free visualization of early cancer hepatic micrometastasis and intraoperative image-guided surgery by photoacoustic imaging.</a> Journal of Nuclear Medicine. 61 (7), 1079-1085 (2020).</li>
</ol>

Marcovich A.L.: Steba Biotech (P), Yeda Weizmann (P), EyeYon Medical (C, P), Mor Isum (P). (C) = Consultant; (P) = Patent. All other authors have no competing interests.

Uveal melanoma is a devastating disease for which novel therapeutic approaches are greatly needed. However, research on uveal melanoma and potential treatments is limited by the technical challenges of uveal melanoma animal models1,25. Ocular tumors, which are induced by intraocular injection of cancer cells, are highly variable in both localization and size, likely due to the small dimensions of the mouse eye. Such variability is an obstacle to the comprehensive...

Uveal melanoma (UM) is the most frequent intraocular primary malignancy in adults. Approximately 90% of ocular melanomas originate from melanocytes in the choroid region of the uveal tract1. UM is a major cause of morbidity and mortality, as it is estimated that close to 50% of patients develop metastatic disease, with the liver being the major site of metastasis2. Early treatment of primary lesions may reduce the chance of metastases, yet no effective treatment prevents metastases formation3.
The standard treatment of uveal melanoma includes irradiation therapy, which is associated with loss of vision due to optic neuropathy, retinopathy, dry eye syndrome, and cataract. Surgical resection is typically delayed until the growth of the lesion is recognized and characterized. However, such a delay may allow metastatic disease development4. In some cases, futile enucleation is required. Of course, this radical procedure compromises vision and results in dramatic aesthetic deterioration.
There have been many efforts dedicated to developing experimental models to study uveal melanoma. Preclinical animal models that allow accurate assessment of this malignancy are key for investigating novel diagnostic and therapeutic strategies for uveal melanoma. Experimental animal models of ocular melanoma are mainly based on the inoculation of tumor cells in mice, rats, and rabbits5,6. Mouse models are cost-effective and widely used for melanoma studies due to their rapid reproduction rate and high genome similarity to humans. The murine cutaneous melanoma cell line B16 is commonly utilized to inoculate C57BL6 mice and induce syngeneic tumors. When using this model to induce uveal melanoma, tumor-bearing eyes typically need to be enucleated 7-14 days after inoculation. Further, B16 is a highly invasive model. The immune-privileged nature of the eye supports metastasis, and metastases may typically be detected 3-4 weeks after tumor cell inoculation. Subcultures of the original B16 line display distinct metastatic properties6. For example, the Queens melanoma line has a high metastatic rate7,8. The B16LS9 cell line has dendritic cell morphology and was derived from liver metastases of C57BL/6 mice injected with the parental cutaneous melanoma line B16F19. When injected into the posterior compartment of the eye, these cells were shown to form intraocular tumors, which histologically resemble human uveal melanoma and form liver-specific metastases in C57BL/6, but not Balb/C, mice10,11,12. Genetically, the cells are characterized by higher expression of the c-met proto-oncogene, which acts as a cellular receptor for hepatocyte growth factor13. In contrast, B16F10, the 10th passage of the parental B16, primarily metastasizes to the lungs when inoculated intraocularly14.&#160;Both B16F10 and B16LS9 are pigmented12.
Several key challenges limit the success of murine uveal melanoma models. First, tumor cell reflux may lead to extraocular or subconjunctival melanoma. Second, tumor growth after intraocular inoculation of melanoma cells is often highly variable, posing difficulties in evaluating treatment and progress. Another major difficulty is the limited ability to follow tumor growth in vivo. While bioluminescent imaging, such as of luciferase expressing tumors, is commonly used to monitor ocular tumor growth15,16, it cannot provide information on the intraocular location of the tumor. Therefore, evaluation of the tumor is typically performed following enucleation of the eye10,17. This greatly limits the ability to characterize tumor progression and response to treatments extensively. Another major hurdle in studying uveal melanoma is the difficulty in monitoring lesions in pigmented mice. New approaches, which overcome these difficulties, are required to promote the research of uveal melanoma in animal models.
Optical coherence tomography (OCT) provides distinctive capabilities to image deep into the different sections of the eye in high resolution, which is unparalleled by other methodologies, including&#160;ultrasound18,19. OCT imaging has been used in animal models to study various ocular diseases20. Recently, OCT imaging was demonstrated as noninvasive means to evaluate intraocular tumor growth21. The protocol described here depicts the implantation of melanoma cells in the murine choroid and the utilization of OCT to predict intraocular tumor localization and size at the time of cell inoculation.

<table><tbody><tr><td>10 &amp;mu;L glass syringe (Hamilton Co., Bonaduz, Switzerland)</td><td>Hamilton</td><td>721711</td><td></td></tr><tr><td>30 G needles</td><td>BD Microbalance</td><td>2025-01</td><td></td></tr><tr><td>Atipamezole hydrochloride</td><td>Orion Phrma</td><td></td><td></td></tr><tr><td>B16LS9 cells</td><td>from Hans Grossniklaus USA</td><td></td><td></td></tr><tr><td>Buprenorphine&amp;nbsp;</td><td>richter pharma</td><td>102047</td><td></td></tr><tr><td>C57BL/6 female mice</td><td>Envigo</td><td></td><td></td></tr><tr><td>Essential vitamin mixture</td><td>satorius</td><td>01-025-1A</td><td></td></tr><tr><td>Fetal bovine serum</td><td>rhenium</td><td>10270106</td><td></td></tr><tr><td>HEPES</td><td>satorius</td><td>03-025-1B</td><td></td></tr><tr><td>Hydroxyethylcellulose 1.4% eye drops</td><td>Fisher Pharmaceutical</td><td>390862</td><td></td></tr><tr><td>InSight OCT segmentation software&amp;nbsp;</td><td>Phoenix Micron, Inc&amp;nbsp;</td><td></td><td></td></tr><tr><td>Ketamine</td><td>bremer pharma GMBH (medimarket)</td><td>17889</td><td></td></tr><tr><td>L-glutamine</td><td>satorius</td><td>03-020-1B</td><td></td></tr><tr><td>Medetomidine&amp;nbsp;</td><td>zoetis (vetmarket)</td><td>102532</td><td></td></tr><tr><td>Ofloxacin 0.3% eye drops</td><td>allergan</td><td>E92170</td><td></td></tr><tr><td>Optical coherence tomography&amp;nbsp;</td><td>Phoenix Micron, Inc&amp;nbsp;</td><td></td><td></td></tr><tr><td>Oxybuprocaine 0.4%</td><td>Fisher Pharmaceutical</td><td>393050</td><td></td></tr><tr><td>Penicillin-streptomycin-amphoteracin</td><td>satorius</td><td>03-033-1B</td><td></td></tr><tr><td>Phosphate buffered saline (PBS)&amp;nbsp;</td><td>satorius</td><td>02-023-1a</td><td></td></tr><tr><td>RPMI cell media</td><td>satorius</td><td>01-104-1A</td><td></td></tr><tr><td>Sodium pyruvate</td><td>satorius</td><td>03-042-1B</td><td></td></tr><tr><td>Surgical microscope</td><td>Zeiss</td><td>OPMI-6 CFC</td><td></td></tr><tr><td>Tropicamide 0.5%</td><td>Fisher Pharmaceutical</td><td>390723</td><td></td></tr></tbody></table>

implantation and evaluation of melanoma in the murine choroid via optical coherence tomography

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Establishing experimental choroidal melanoma models is challenging in terms of the ability to induce tumors at the correct localization. In addition, difficulties in observing posterior choroidal melanoma in vivo limit tumor location and growth evaluation in real-time. The approach described here optimizes techniques for establishing choroidal melanoma in mice via a multi-step sub-choroidal B16LS9 cell injection procedure. To enable precision in injecting into the small dimensions of the mouse uvea, the complete procedure is performed under a microscope. First, a conjunctival peritomy is formed in the dorsal-temporal area of the eye. Then, a tract into the sub-choroidal space is created by inserting a needle through the exposed sclera. This is followed by the insertion of a blunt needle into the tract and the injection of melanoma cells into the choroid. Immediately after injection, noninvasive optical coherence tomography (OCT) imaging is utilized to determine tumor location and progress. Retinal detachment is evaluated as a predictor of tumor site and size. The presented method enables the reproducible induction of choroid-localized melanoma in mice and the live imaging of tumor growth evaluation. As such, it provides a valuable tool for studying intraocular tumors.

Eyes were examined via OCT immediately after injection of the B16LS9 cells. Local retinal detachment was observed after injection. The mice exhibited three patterns of RD: focal (Figure 2, upper panel), leakage to the vitreous (Figure 2, middle panel), and extended RD (Figure 2, bottom panel). Extended RD is likely caused by damage from the injection. There was an association between the pattern of RD immediately after inje...

The present protocol describes the implantation and evaluation of melanoma in the murine choroid utilizing optical coherence tomography.

Establishing experimental choroidal melanoma models is challenging in terms of the ability to induce tumors at the correct localization. In addition, ...

implantation-evaluation-melanoma-murine-choroid-via-optical-coherence

Research

JoVE Journal

Cancer Research

This video demonstrates an in vivo imaging technique for detecting and quantifying eye inflammation in a mouse model of post-infectious uveitis. The technique, known as optical coherence tomography (OCT), generates high-resolution cross-sectional images of the eye for assessing disease progression.

Optical Coherence Tomography Imaging for Assessing Uveitis in a Mouse Model

Source: Jagodzinska, J., et. al.,  Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo. J. Vis. Exp. (2017)  In this video, we demonstrate the use of spectral-domain optical coherence tomography (SD-OCT) to image retinal layers and assess structural changes in a genetically modified mouse model with optic neuropathy.

In Vivo Imaging of the Mouse Retina Using Optical Coherence Tomography

We have established a cortical orthotopic glioblastoma model in mice for intravital two-photon microscopy that recapitulates the biophysical constraints normally at play during the growth of the tumor. A chronic glass window replacing the skull above the tumor enables the follow-up of the tumor progression over time by two-photon microscopy.

An Orthotopic Glioblastoma Mouse Model Maintaining Brain Parenchymal Physical Constraints and Suitable for Intravital Two-photon Microscopy

We describe a non-invasive animal imaging platform that allows the detection, quantification, and monitoring of ovarian cancer growth and recurrence. This intra-peritoneal xenograft model mimics the clinical profile of patients with ovarian cancer.

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

This manuscript describes a protocol for the in vivo imaging of the mouse retina with high-resolution spectral domain optical coherence tomography (SD-OCT). It focuses on retinal ganglion cells (RGC) in the peripapillary region, with several scanning and quantifying approaches described.

Optical Coherence Tomography: Imaging Mouse Retinal Ganglion Cells In Vivo

Here, we present the usefulness of longitudinal in vivo imaging in the follow-up of morphological changes of laser-induced choroidal neovascularization in mice.

In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model

The following procedure describes a method for spatial and temporal control of melanocytic tumor initiation in murine dorsal skin, using a genetically engineered mouse model. This protocol describes macroscopic as well as microscopic cutaneous melanoma initiation.

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Here, we describe an in vivo imaging technique using optical coherence tomography to facilitate the diagnosis and quantitative measurement of retinopathy in mice.

Application of Optical Coherence Tomography to a Mouse Model of Retinopathy

The present protocol outlines the steps for aligning in vivo visible-light optical coherence tomography fibergraphy (vis-OCTF) images with ex vivo confocal images of the same mouse retina for the purpose of verifying the observed retinal ganglion cell axon bundle morphology in the in vivo images.

Alignment of Visible-Light Optical Coherence Tomography Fibergrams with Confocal Images of the Same Mouse Retina

We describe a method using targeted peripheral irradiation to induce fatigue-like behavior in mice. The selected non-lethal irradiation dose leads to a week-long reduction in voluntary wheel-running activity.

A Mouse Model of Fatigue Induced by Peripheral Irradiation

Learn to implant and evaluate melanoma in the murine choroid using optical coherence tomography for live tumor imaging. This method enables reproducible tumor induction and continuous monitoring to advance uveal melanoma research.

Implantation and Evaluation of Melanoma in the Murine Choroid via Optical Coherence Tomography

Explore More Videos